REG - ReNeuron Group plc - Director Share Purchase
RNS Number : 7377PReNeuron Group plc21 October 2021ReNeuron Group plc
("ReNeuron" or the "Company")
Share Purchase by a Director
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, was informed that on the 20 October 2021, the following purchase of the Company's ordinary shares of 1p each ("Ordinary Shares") was made by a director of the Company:
Name
Title
Number of Ordinary Shares purchased
Total beneficial interest in the Company's Ordinary Shares
Percentage of Company's Total Voting Rights
Barbara Staehelin
Senior Independent
Non-Executive Director
43,000
43,000
0.08%
ENDS
Contacts:
ReNeuron
Olav Hellebø, Chief Executive Officer
Catherine Isted, Chief Financial Officer
Via Walbrook PR
Stifel Nicolaus Europe Limited (NOMAD and Joint Broker)
Ben Maddison, Stewart Wallace
+44 (0)20 7710 7600
Allenby Capital Limited (Joint Broker)
+44 (0)20 3328 5656
James Reeve/George Payne (Corporate Finance)
Stefano Aquilino (Sales & Corporate Broking)
Walbrook PR (Media & Investor Relations)
+44 (0)20 7933 8780 or reneuron@walbrookpr.com
Paul McManus / Alice Woodings
+44 (0)7980 541 893 / +44 (0)7407 804 654
About ReNeuron
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs. The Company's lead cell therapy candidate is in clinical development for the blindness-causing disease, retinitis pigmentosa.
ReNeuron is also advancing its proprietary exosome technology platform as a potential delivery system for drugs that treat diseases of the brain. The Company also has the ability through its conditionally immortalised induced pluripotent stem cell (iPSC) platform to make any tissue cells of choice; in-house programmes are focused on treatments for blood cancers and diabetes.
ReNeuron's shares are traded on the London AIM market under the symbol RENE.L. For further information visit www.reneuron.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
(Disclosure in relation to share options granted to Directors and PDMRs)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Barbara Staehelin
2
Reason for the notification
a)
Position/status
Senior Independent Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ReNeuron Group plc
b)
LEI
2138003TU12CQ5TZO137
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares 1p
RENE - GB00BF5G6K95
b)
Nature of the transaction
Acquisition of ordinary shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
115p
43,000
d)
Aggregated information
£49,450
e)
Date of the transaction
20 October 2021
f)
Place of the transaction
London Stock Exchange AIM Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHURVWRAAURUAA
Recent news on ReNeuron
See all newsREG - ReNeuron Group plc - Creditor’s decision on Administrators' Proposals
AnnouncementREG - ReNeuron Group plc - Publication of Joint Administrators' Proposals
AnnouncementREG - ReNeuron Group plc - Update on Administration Process
AnnouncementREG - ReNeuron Group plc - Directorate Change
AnnouncementREG - FTSE Russell - ReNeuron Group
Announcement